GUMDROP : HUH - Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Created by Nancy Dawson, last modified on Sep 18, 2013
Description:The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).
Link:http://clinicaltrials.gov/ct2/show/study/NCT01727154
Site:Howard University Hospital
Principle Investigator:Chiledum A. Ahaghotu, MD